Skip to main content
. 2018 Nov 12;8(11):112. doi: 10.1038/s41408-018-0151-y

Fig. 1.

Fig. 1

Effect of hydroxyurea (HU) on the cumulative incidence of recurrent arterial thrombosis after an arterial event (top panel) and of recurrent venous thrombosis after a venous thromboembolism (VTE) at common sites (i.e., legs and pulmonary vessels) (middle panel) or after a splanchnic vein thrombosis (SVT) (bottom panel)